Clinical Trial Update: Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bavituximab in combination with radiation and temozolomide for newly diagnosed glioblastoma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bavituximab (bavituximab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16